Page 62 - Zai Lab News Today

Shares of Zai Lab Limited (NASDAQ:ZLAB – Get Rating) have earned a consensus recommendation of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. […]

Segantii Capital Management Ltd increased its position in shares of Zai Lab Limited (NASDAQ:ZLAB – Get Rating) by 96.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,393,000 shares of the company’s stock after acquiring an additional 685,003 shares during the period. Zai Lab […]

Eisai has decided to exit its supporting role for Biogen's Alzheimer's drug Aduhelm. Chinese companies including several biotechs face potential U.S.

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB). Such investors are...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., March 15, 2022 -- Zai Lab Limited , a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced the... | March 15, 2022

Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer SHANGHAI, SAN FRANCISCO, and CAMBRIDGE, Mass. March 15, 2022 -Zai Lab Limited , a... | March 15, 2022

Deemed to have "exhibited poor judgment," Josh Smiley departed Eli Lilly last year and left about $24 million in cash and equity on the table.

Shares of Chinese stocks listed in the U.S. tumbled Monday as investors reassess their positions amid renewed delisting fears